Luciferase Reporter Cancer Cell Lines
CAR-T cell-based therapeutics have emerged as a promising immunotherapy for treating specific leukemias, lymphomas, and myelomas.
CAR-T cell-based therapeutics have emerged as a promising immunotherapy for treating specific leukemias, lymphomas, and myelomas.
At In Vitro Technologies, we are always striving to provide a solution to your research needs.
We are excited to bring to you some big savings on our world-class equipment. Hurry we only have limited stock to move so these offers won't last long.
Together with Protein Simple, letâs change the way you analyse proteins! Use cutting-edge technologies to improve workflow and accelerate your discoveries.With a range of analytical instruments, you can now automate:-...
Reach a higher level of automation and batch consistency with the innovative CITSens Bio APC systemC-CIT Sensors aims to revolutionize the fields of upstream bioprocessing, cell therapy and regenerative medicine...
ATCC cells are isolated from specific tissue types to support research in disease mechanisms, tissue biology, iPS cell technology, and regenerative medicine.Traditional attention to quality makes ATCC your most reliable...
To accelerate your biological manufacturing processes in cell therapy and gene therapy, In Vitro Technologies is offering a package solution.The Infors Minifors 2 bench-top bioreactor offers features beyond those of...
Recently, researchers at Queenslandâs QIMR Berghofer Institute clearly demonstrated that the newer Omicron variant BA.5 has increased neuropathology over BA.1 using human brain organoids and a mouse model.Click here for...
We are excited to bring to you some big savings on our world-class equipment range!Hurry we only have limited stock to move, so these offers won't last long! If you...